Protocol to request
Receptor preparation for in silico studies and molecular screening of FDA-approved drugs
Short report
Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2
Mohammad Afsar et al.
DOI: 10.7554/eLife.74877